FAVAX | VVIAX | FAVAX / VVIAX | |
Total Expense Ratio | 0.93 | 0.05 | 1,860% |
Annual Report Gross Expense Ratio | 0.93 | 0.05 | 1,860% |
Fund Existence | 24 years | 25 years | - |
Gain YTD | 6.719 | 6.517 | 103% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 203M | 196B | 0% |
Annual Yield % from dividends | 1.53 | 2.18 | 70% |
Returns for 1 year | 3.27 | 7.91 | 41% |
Returns for 3 years | 11.27 | 25.93 | 43% |
Returns for 5 years | 50.17 | 68.54 | 73% |
Returns for 10 years | 60.39 | 114.61 | 53% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MRSGX | 24.03 | 0.17 | +0.71% |
MFS Research International R1 | |||
GREIX | 11.76 | 0.07 | +0.60% |
Goldman Sachs Real Estate Securities Ins | |||
MMUGX | 24.43 | -0.02 | -0.08% |
MFS Utilities R1 | |||
RDLCX | 10.09 | -0.01 | -0.10% |
Columbia Disciplined Growth C | |||
NVLIX | 66.20 | -0.14 | -0.21% |
Nuveen Winslow Large-Cap Growth ESG I |